Rochelle M. Long

1.4k total citations
25 papers, 694 citations indexed

About

Rochelle M. Long is a scholar working on Pharmacology, Molecular Biology and Cancer Research. According to data from OpenAlex, Rochelle M. Long has authored 25 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pharmacology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Rochelle M. Long's work include Pharmacogenetics and Drug Metabolism (8 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Rochelle M. Long is often cited by papers focused on Pharmacogenetics and Drug Metabolism (8 papers), Drug-Induced Hepatotoxicity and Protection (6 papers) and Drug Transport and Resistance Mechanisms (5 papers). Rochelle M. Long collaborates with scholars based in United States, United Kingdom and Russia. Rochelle M. Long's co-authors include Douglas E. Rickert, Leon Moore, Lee E. Moore, Pascal Chartrand, Robert H. Singer, Lance R. Pohl, Frank J. Gonzalez, Brian M. Martin, Hiroko Satoh and Shioko Kimura and has published in prestigious journals such as Current Biology, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Rochelle M. Long

25 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rochelle M. Long United States 14 332 198 129 94 75 25 694
David G. Thomassen United States 21 331 1.0× 250 1.3× 156 1.2× 139 1.5× 41 0.5× 37 948
Ryuichi Kato Japan 10 281 0.8× 182 0.9× 194 1.5× 76 0.8× 38 0.5× 15 633
Ronald Chanderbhan United States 17 587 1.8× 88 0.4× 106 0.8× 160 1.7× 33 0.4× 23 1.1k
Carmen Laethem United States 14 312 0.9× 306 1.5× 115 0.9× 104 1.1× 77 1.0× 18 901
D E Williams United States 13 310 0.9× 191 1.0× 93 0.7× 80 0.9× 26 0.3× 16 662
Adrian Davies United Kingdom 10 201 0.6× 200 1.0× 110 0.9× 90 1.0× 76 1.0× 17 634
Alan Anderson Canada 17 360 1.1× 444 2.2× 153 1.2× 254 2.7× 33 0.4× 36 838
Masato Kitajima Japan 15 261 0.8× 122 0.6× 62 0.5× 113 1.2× 69 0.9× 20 607
Mi-Sook Dong South Korea 10 452 1.4× 183 0.9× 69 0.5× 68 0.7× 35 0.5× 10 690
Kim J. Rich United Kingdom 13 173 0.5× 281 1.4× 152 1.2× 175 1.9× 58 0.8× 21 598

Countries citing papers authored by Rochelle M. Long

Since Specialization
Citations

This map shows the geographic impact of Rochelle M. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rochelle M. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rochelle M. Long more than expected).

Fields of papers citing papers by Rochelle M. Long

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rochelle M. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rochelle M. Long. The network helps show where Rochelle M. Long may publish in the future.

Co-authorship network of co-authors of Rochelle M. Long

This figure shows the co-authorship network connecting the top 25 collaborators of Rochelle M. Long. A scholar is included among the top collaborators of Rochelle M. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rochelle M. Long. Rochelle M. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Filipski, Kelly K., Leah E. Mechanic, Rochelle M. Long, & Andrew N. Freedman. (2014). Pharmacogenomics in oncology care. Frontiers in Genetics. 5. 73–73. 30 indexed citations
2.
Long, Rochelle M.. (2007). Planning for a National Effort to Enable and Accelerate Discoveries in Pharmacogenetics: The NIH Pharmacogenetics Research Network. Clinical Pharmacology & Therapeutics. 81(3). 450–454. 10 indexed citations
3.
Davis, Alison F. & Rochelle M. Long. (2004). Pharmacogenetics Research Network and Knowledge Base Fourth Scientific Meeting. The Pharmacogenomics Journal. 4(6). 359–361. 5 indexed citations
4.
Davis, Alison F. & Rochelle M. Long. (2003). Pharmacogenetics Research Network and Knowledge Base Third Scientific Meeting. Pharmacogenetics. 13(7). 437–440. 2 indexed citations
5.
Davis, Alison F. & Rochelle M. Long. (2001). Pharmacogenetics Research Network and Knowledge Base: 1st Annual Scientific Meeting. Pharmacogenomics. 2(3). 285–289. 7 indexed citations
6.
Chartrand, Pascal, et al.. (1999). Structural elements required for the localization of ASH1 mRNA and of a green fluorescent protein reporter particle in vivo. Current Biology. 9(6). 333–338. 161 indexed citations
7.
Long, Rochelle M.. (1997). News from the National Institute of General Medical Sciences (NIGMS). Pharmaceutical Research. 14(1). 1–1. 2 indexed citations
8.
Long, Rochelle M., et al.. (1991). Cloning and sequencing of a human liver carboxylesterase isoenzyme. Life Sciences. 48(11). PL43–PL49. 30 indexed citations
9.
Wang, Shou Zhen, et al.. (1990). Agonist‐induced down‐regulation of m1 muscarinic receptors and reduction of their mRNA level in a transfected cell line. FEBS Letters. 276(1-2). 185–188. 27 indexed citations
10.
Moore, Lee E., Daniel R. Schoenberg, & Rochelle M. Long. (1990). Impact of halogenated compounds on calcium homeostasis in hepatocytes.. Environmental Health Perspectives. 84. 149–153. 7 indexed citations
11.
Moore, Leon C., Daniel R. Schoenberg, & Rochelle M. Long. (1990). Impact of Halogenated Compounds on Calcium Homeostasis in Hepatocytes. Environmental Health Perspectives. 84. 149–149. 1 indexed citations
12.
Long, Rochelle M., Leon Moore, & Daniel R. Schoenberg. (1989). Halocarbon hepatotoxicity is not initiated by Ca2+-stimulated endonuclease activation. Toxicology and Applied Pharmacology. 97(2). 350–359. 14 indexed citations
13.
Long, Rochelle M. & Lee E. Moore. (1988). Evaluation of the calcium mobilizing action of acetaminophen and bromobenzene in rat hepatocyte cultures. Journal of Biochemical Toxicology. 3(4). 353–362. 10 indexed citations
14.
Long, Rochelle M., Hiroko Satoh, Brian M. Martin, et al.. (1988). Rat liver carboxylesterase: cDNA cloning, sequencing, and evidence for a multigene family. Biochemical and Biophysical Research Communications. 156(2). 866–873. 72 indexed citations
15.
Long, Rochelle M. & Leon Moore. (1988). Biochemical evaluation of rat hepatocyte primary cultures as a model for carbon tetrachloride hepatotoxicity: Comparative studies in vivo and in vitro. Toxicology and Applied Pharmacology. 92(2). 295–306. 26 indexed citations
16.
Rickert, Douglas E., Rochelle M. Long, Martin C. Dyroff, & Gregory L. Kedderis. (1984). Hepatic macromolecular covalent binding of mononitrotoluenes in Fischer-344 rats. Chemico-Biological Interactions. 52(2). 131–139. 13 indexed citations
17.
Rickert, Douglas E., et al.. (1983). Hepatic macromolecular covalent binding and intestinal disposition of [14C]dinitrotoluenes. Journal of Toxicology and Environmental Health. 11(4-6). 555–567. 10 indexed citations
18.
Rickert, Douglas E., James A. Bond, Rochelle M. Long, & John P. Chism. (1983). Metabolism and excretion of nitrobenzene by rats and mice. Toxicology and Applied Pharmacology. 67(2). 206–214. 20 indexed citations
19.
Long, Rochelle M. & Douglas E. Rickert. (1982). Metabolism and excretion of 2,6-dinitro [14C]toluene in vivo and in isolated perfused rat livers.. Drug Metabolism and Disposition. 10(5). 455–458. 36 indexed citations
20.
Rickert, Douglas E. & Rochelle M. Long. (1981). Metabolism and excretion of 2,4-dinitrotoluene in male and female Fischer 344 rats after different doses.. Drug Metabolism and Disposition. 9(3). 226–232. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David G. Thomassen Breakdown of academic impact, for papers by Ryuichi Kato Breakdown of academic impact, for papers by Ronald Chanderbhan Breakdown of academic impact, for papers by Carmen Laethem Breakdown of academic impact, for papers by D E Williams Breakdown of academic impact, for papers by Adrian Davies Breakdown of academic impact, for papers by Alan Anderson Breakdown of academic impact, for papers by Masato Kitajima Breakdown of academic impact, for papers by Mi-Sook Dong Breakdown of academic impact, for papers by Kim J. Rich
Rankless by CCL
2026